These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38586458)

  • 1. External validation of a minimal-resource model to predict reduced estimated glomerular filtration rate in people with type 2 diabetes without diagnosis of chronic kidney disease in Mexico: a comparison between country-level and regional performance.
    Sammut-Powell C; Sisk R; Silva-Tinoco R; de la Pena G; Almeda-Valdes P; Juarez Comboni SC; Goncalves S; Cameron R
    Front Endocrinol (Lausanne); 2024; 15():1253492. PubMed ID: 38586458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Yield of Population-Based Screening for Chronic Kidney Disease in Low-Income, Middle-Income, and High-Income Countries.
    Tonelli M; Tiv S; Anand S; Mohan D; Garcia Garcia G; Gutiérrez Padilla JA; Klarenbach S; Navarro Blackaller G; Seck S; Wang J; Zhang L; Muntner P
    JAMA Netw Open; 2021 Oct; 4(10):e2127396. PubMed ID: 34605917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for chronic kidney disease in a community-based diabetes cohort in rural Guatemala: a cross-sectional study.
    Flood D; Garcia P; Douglas K; Hawkins J; Rohloff P
    BMJ Open; 2018 Jan; 8(1):e019778. PubMed ID: 29358450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albuminuria and Glomerular Filtration Rate in Individuals with Type 1 Diabetes Mellitus: Contribution of Metabolic Syndrome.
    Uribe-Wiechers AC; Janka-Zires M; Almeda-Valdés P; López-Gutiérrez J; Gómez-Pérez FJ
    Rev Invest Clin; 2015; 67(4):266-72. PubMed ID: 26426593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synergistic effect of variability in estimated glomerular filtration rate with chronic kidney disease on all-cause mortality prediction in patients with type 2 diabetes: a retrospective cohort study.
    Chang YS; Li YH; Lee IT
    Cardiovasc Diabetol; 2021 Oct; 20(1):209. PubMed ID: 34663321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prediction model on incident chronic kidney disease among individuals with type 2 diabetes in the United States.
    Lin Y; Shao H; Fonseca V; Anderson AH; Batuman V; Shi L
    Diabetes Obes Metab; 2023 Oct; 25(10):2862-2868. PubMed ID: 37334525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a risk prediction model for chronic kidney disease among individuals with type 2 diabetes.
    Lin CC; Niu MJ; Li CI; Liu CS; Lin CH; Yang SY; Li TC
    Sci Rep; 2022 Mar; 12(1):4794. PubMed ID: 35314714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AWAREness of Diagnosis and Treatment of Chronic Kidney Disease in Adults With Type 2 Diabetes (AWARE-CKD in T2D).
    Chu L; Bhogal SK; Lin P; Steele A; Fuller M; Ciaccia A; Abitbol A
    Can J Diabetes; 2022 Jul; 46(5):464-472. PubMed ID: 35739044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for chronic kidney disease in rural Malawi: results from a diabetic clinic.
    Kachimanga C; Kamwezi R; Wroe EB; Nazimera L; Ndarama E; Thengo L; Talama GC
    BMC Res Notes; 2019 Jul; 12(1):375. PubMed ID: 31262351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Prediction for Early CKD in Type 2 Diabetes.
    Dunkler D; Gao P; Lee SF; Heinze G; Clase CM; Tobe S; Teo KK; Gerstein H; Mann JF; Oberbauer R;
    Clin J Am Soc Nephrol; 2015 Aug; 10(8):1371-9. PubMed ID: 26175542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) México and comparison with KEEP US.
    Obrador GT; García-García G; Villa AR; Rubilar X; Olvera N; Ferreira E; Virgen M; Gutiérrez-Padilla JA; Plascencia-Alonso M; Mendoza-García M; Plascencia-Pérez S
    Kidney Int Suppl; 2010 Mar; (116):S2-8. PubMed ID: 20186176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care.
    Metsärinne K; Bröijersen A; Kantola I; Niskanen L; Rissanen A; Appelroth T; Pöntynen N; Poussa T; Koivisto V; Virkamäki A;
    Prim Care Diabetes; 2015 Feb; 9(1):31-8. PubMed ID: 25066820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of resource-driven risk prediction models for incident chronic kidney disease in type 2 diabetes.
    Gurudas S; Nugawela M; Prevost AT; Sathish T; Mathur R; Rafferty JM; Blighe K; Rajalakshmi R; Mohan AR; Saravanan J; Majeed A; Mohan V; Owens DR; Robson J; Sivaprasad S;
    Sci Rep; 2021 Jul; 11(1):13654. PubMed ID: 34211028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of chronic kidney disease using estimated glomerular filtration rate among diabetes patients attending a tertiary clinic in Botswana.
    Rwegerera GM; Molefe-Baikai OJ; Masaka A; Shimwela M; Rivera YP; Oyewo TA; Godman BB; Massele A; Habte D
    Hosp Pract (1995); 2018 Oct; 46(4):214-220. PubMed ID: 30058409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The burden of unrecognised chronic kidney disease in patients with type 2 diabetes at a county hospital clinic in Kenya: implications to care and need for screening.
    Otieno FCF; Ogola EN; Kimando MW; Mutai K
    BMC Nephrol; 2020 Feb; 21(1):73. PubMed ID: 32111192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and risk factors for chronic kidney disease in primary health care in the southern region of New Zealand.
    Lloyd H; Li G; Tomlin A; Tilyard MW; Walker R; Schollum J
    Nephrology (Carlton); 2019 Mar; 24(3):308-315. PubMed ID: 29717528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of Diabetes and Kidney Disease Screening Scores in Contemporary United States and Korean Populations.
    Meng L; Kwon KS; Kim DJ; Lee YH; Kim J; Kshirsagar AV; Bang H
    Diabetes Metab J; 2022 Mar; 46(2):273-285. PubMed ID: 34503311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leveraging the South African Diabetes Prevention Programme to screen for chronic kidney disease: an observational study.
    George C; Hill J; Nqebelele U; Peer N; Kengne AP
    BMJ Open; 2023 Jan; 13(1):e068672. PubMed ID: 36609330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of minimal resource pre-screening tools for chronic kidney disease in people with type 2 diabetes.
    Sammut-Powell C; Sisk R; Budd J; Patel N; Edge M; Cameron R
    Future Healthc J; 2022 Nov; 9(3):305-309. PubMed ID: 36561833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External validation of prognostic models for chronic kidney disease among type 2 diabetes.
    Saputro SA; Pattanateepapon A; Pattanaprateep O; Aekplakorn W; McKay GJ; Attia J; Thakkinstian A
    J Nephrol; 2022 Jul; 35(6):1637-1653. PubMed ID: 34997924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.